Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 278 participants.
Also called NCT02413515
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 278 participants
- Sponsor
- Registry
-
NCT02413515
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02413515. Allocation not applicable; no masking; primary purpose treatment. Start 2015-03-26 (actual); primary completion 2016-08-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.
- Acronym
- ADEPT
- Condition
- Hypertension
- Intervention (Drug)
- Nifedipine (Adalat GITS, BAY1040)
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct02413515- Content hash
b8d08534f5e28b88d40a6525292c899ba77d17b47052b95834e8c3ad8b440994